Reductions in cardiovascular risk associated with dapagliflozin treatment in patients with type 2 diabetes are most pronounced in those who have both reduced kidney function and albuminuria, a recent analysis shows.
Even a single episode of hyperkalemia is associated with a major disease burden, a study finds.
Diabetes linked to increased risks for primary outcome of cardiovascular death, MI, stroke and secondary outcomes
Additionally, among patients with Parkinson disease, type 2 diabetes tied to more rapid Parkinson progression
Anavip contains venom-specific F(ab’)2 fragments of immunoglobulin G that bind and neutralize venom toxins.
Maintaining treatment resulted in continued weight loss during additional 48 weeks compared with switching to placebo.
This meta-analysis aimed to determine the association between SGLT2i use and arrhythmias in patients with T2DM or HF.
Prescriptions for short-acting hormonal methods, such as pills and injections, declined in the year after diabetes diagnosis
Zegalogue is a glucagon analogue that is formulated in a ready-to-use aqueous solution for subcutaneous administration.
Intensive lifestyle intervention may be detrimental for overweight, obese patients with type 2 diabetes who have poor glycemic control
